Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3414-3417

  Arrighi, Romanico B G ^a,c   Ebikeme, Charles ^b   Jiang, Yang ^a   Ranford Cartwright, Lisa ^b   Barrett, Michael P ^b   Langel, Ülo ^a   Faye, Ingrid ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE PVEC; CELL PENETRATING PEPTIDE TP10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALARIA FALCIPARUM; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TRYPANOSOMA BRUCEI;

AMINO ACID SEQUENCE; ANIMALS; ANTIMALARIALS; CELL MEMBRANE; HUMANS; MOLECULAR SEQUENCE DATA; PARASITIC SENSITIVITY TESTS; PEPTIDES; PLASMODIUM FALCIPARUM; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

EID: 50949131187     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01450-07     Document Type: Article

References (36)

1. Arrighi, R. B., C. Nakamura, J. Miyake, H. Hurd, and J. G. Burgess. 2002. Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias. Antimicrob. Agents Chemother. 46:2104-2110.
2. Barrett, M. P., R. J. Burchmore, A. Stich, J. O. Lazzari, A. C. Frasch, J. J. Cazzulo, and S. Krishna. 2003. The trypanosomiases. Lancet 362:1469-1480.
3. Bell, A. S., and L. C. Ranford-Cartwright. 2004. A real-time PCR assay for quantifying Plasmodium falciparum infections in the mosquito vector. Int. J. Parasitol. 34:795-802.
4. Blandin, S., L. F. Moita, T. Kocher, M. Wilm, F. C. Kafatos, and E. A. Levashina. 2002. Reverse genetics in the mosquito Anopheles gambiae: targeted disruption of the Defensin gene. EMBO Rep. 3:852-856.
5. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
6. Carter, R., L. C. Ranford-Cartwright, and P. Alano. 1993. The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies, p. 67-89. In J. E. Hyde (ed.), Methods in molecular biology, vol 21. Protocols in molecular parasitology. Humana Press Inc., Totowa, NJ.
7. Conde, R., F. Z. Zamudio, M. H. Rodriguez, and L. D. Possani. 2000. Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett. 471:165-168.
8. Dagan, A., L. Efron, L. Gaidukov, A. Mor, and H. Ginsburg. 2002. In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 46:1059-1066.
9. Elmquist, A., M. Lindgren, T. Bartfai, and Ü. Langel. 2001. VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell Res. 269:237-244.
10. Guergnon, J., F. Dessauge, V. Dominguez, J. Viallet, S. Bonnefoy, V. J. Yuste, O. Mercereau-Puijalon, X. Cayla, A. Rebollo, S. A. Susin, P. E. Bost, and A. Garcia. 2006. Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology. Mol. Pharmacol. 69:1115-1124.
11. Guillaume, C., C. Deregnaucourt, V. Clavey, and J. Schrevel. 2004. Anti-Plasmodium properties of group IA, IB, IIA and III secreted phospholipascs A2 are serum-dependent. Toxicon 43:311-318.
12. Henriques, S. T., M. N. Melo, and M. A. Castanho. 2006. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399:1-7.
13. Hill, C. A., F. C. Kafatos, S. K. Stansfield, and F. H. Collins. 2005. Arthropod-borne diseases: vector control in the genomics era. Nat. Rev. Microbiol. 3:262-268.
14. Hirai, M., and I. Faye. 2004. Evaluation of parasitemia by lactate dehydrogenase assay, p. 21-22. In I. Ljungstrom, H. Perlmann, M. Schlichtherle, A. Scherf, and M. Wahlgren (ed.), Methods in malaria research, 4th ed. MR4/ATCC, Manassas, VA.
15. Hirumi, H., and K. Hirumi. 1994. Axenic culture of African trypanosome bloodstream forms. Parasitol. Today 10:80-84.
16. Hu, Y., and S. Aksoy. 2005. An antimicrobial peptide with trypanocidal activity characterized from Glossina morsitans morsitans. Insect Biochem. Mol. Biol. 35:105-115.
17. Hurd, H., P. J. Taylor, D. Adams, A. Underhill, and P. Eggleston. 2005. Evaluating the costs of mosquito resistance to malaria parasites. Evolution 59:2560-2572.
18. Jiang, Y., U. Soomets, and Ü. Langel. 2006. Design and synthesis of cell-penetrating peptides, p. 537-552. In Ü. Langel (ed.), Handbook of cell-penetrating peptides, 2nd ed. Taylor & Francis, Boca Raton, FL.
19. Kirk, K., H. M. Staines, R. E. Martin, and K. J. Saliba. 1999. Transport properties of the host cell membrane. Novartis Found. Symp. 226:55-66.
20. Kumar, S., M. Guha, V. Choubey, P. Maity, and U. Bandyopadhyay. 2007. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Life Sci. 80:813-828.
21. Levashina, E. A. 2004. Immune responses in Anopheles gambiae. Insect Biochem. Mol. Biol. 34:673-678.
22. Mae, M., H. Myrberg, Y. Jiang, H. Paves, A. Valkna, and Ü. Langel. 2005. Internalisation of cell-penetrating peptides into tobacco protoplasts. Biochim. Biophys. Acta 1669:101-107.
23. McGwire, B. S., C. L. Olson, B. F. Tack, and D. M. Engman. 2003. Killing of African trypanosomes by antimicrobial peptides. Infect. Dis. 188:146-152.
24. Nekhotiaeva, N., A. Elmquist, G. K. Rajarao, M. Hallbrink, Ü. Langel, and L. Good. 2004. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J. 18:394-396.
25. Padari, K., P. Saalik, M. Hansen, K. Koppel, R. Raid, Ü. Langel, and M. Pooga. 2005. Cell transduction pathways of transportans. Bioconjug. Chem. 16:1399-1410.
26. Palm, C., S. Netzereab, and M. Hällbrink. 2006. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 27:1710-1716.
27. Parenteau, J., R. Klinck, L. Good, Ü. Langel, R. J. Wellinger, and S. A. Elela. 2005. Free uptake of cell-penetrating peptides by fission yeast. FEBS Lett. 579:4873-4878.
28. Peschel, A., and H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
29. Raz, B., M. Iten, Y. Grether-Buhler, R. Kaminsky, and R. Brun. 1997. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop. 68:139-147.
30. RBM Partnership. 2005. World malaria report 2005. http://rollbackmalaria.org/wmr2005/.
31. Savoia, D., S. Scutera, S. Raimondo, S. Conti, W. Magliani, and L. Polonelli. 2006. Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. Exp. Parasitol. 113:186-192.
32. Soomets, U., M. Lindgren, X. Gallet, M. Hällbrink, A. Elmquist, L. Balaspiri, M. Zorko, M. Pooga, R. Brasseur, and Ü. Langel. 2000. Deletion analogues of transportan. Biochim. Biophys. Acta 1467:165-176.
33. Stewart, M. L., G. J. Bueno, A. Baliani, B. Klenke, R. Brun, J. M. Brock, I. H. Gilbert, and M. P. Barrett. 2004. Trypanocidal activity of melamine-based nitroheterocycles. Antimicrob. Agents Chemother. 48:1733-1738.
34. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
35. Yandek, L. E., A. Pokorny, A. Floren, K. Knoelke, Ü. Langel, and P. F. Almeida. 2007. Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers. Biophys. J. 92:2434-2444.
36. Zorko, M., and Ü. Langel. 2005. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug. Deliv. Rev. 57:529-545.